Culbertson A N & Co. Inc. Has $471,000 Holdings in The Clorox Company $CLX

Culbertson A N & Co. Inc. decreased its position in The Clorox Company (NYSE:CLX) by 74.3% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,824 shares of the company’s stock after selling 11,043 shares during the quarter. Culbertson A N & Co. Inc.’s holdings in Clorox were worth $471,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently modified their holdings of CLX. Vanguard Group Inc. raised its position in Clorox by 1.7% in the 2nd quarter. Vanguard Group Inc. now owns 15,845,496 shares of the company’s stock valued at $1,902,569,000 after buying an additional 272,420 shares during the last quarter. Invesco Ltd. grew its stake in shares of Clorox by 138.3% during the 2nd quarter. Invesco Ltd. now owns 3,245,175 shares of the company’s stock worth $389,648,000 after acquiring an additional 1,883,465 shares in the last quarter. Norges Bank acquired a new stake in shares of Clorox in the second quarter valued at approximately $190,429,000. Arrowstreet Capital Limited Partnership lifted its position in shares of Clorox by 218.4% in the second quarter. Arrowstreet Capital Limited Partnership now owns 1,249,127 shares of the company’s stock worth $149,983,000 after purchasing an additional 856,873 shares in the last quarter. Finally, ProShare Advisors LLC boosted its holdings in Clorox by 7.0% during the second quarter. ProShare Advisors LLC now owns 1,160,881 shares of the company’s stock worth $139,387,000 after purchasing an additional 75,514 shares during the last quarter. 78.53% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Clorox

In related news, Director Pierre R. Breber acquired 4,000 shares of the company’s stock in a transaction dated Friday, November 21st. The shares were bought at an average cost of $104.13 per share, with a total value of $416,520.00. Following the completion of the transaction, the director directly owned 13,000 shares of the company’s stock, valued at $1,353,690. This trade represents a 44.44% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through the SEC website. 0.63% of the stock is owned by insiders.

Analysts Set New Price Targets

CLX has been the topic of several recent research reports. JPMorgan Chase & Co. lowered their price target on shares of Clorox from $127.00 to $120.00 and set a “neutral” rating on the stock in a research note on Tuesday, November 4th. Bank of America lowered their target price on Clorox from $135.00 to $125.00 and set a “neutral” rating on the stock in a research report on Wednesday, October 8th. Barclays dropped their target price on Clorox from $112.00 to $108.00 and set an “underweight” rating on the stock in a report on Tuesday, November 4th. Jefferies Financial Group restated a “buy” rating and issued a $152.00 price target on shares of Clorox in a research note on Tuesday, November 4th. Finally, UBS Group set a $119.00 price objective on Clorox and gave the stock a “neutral” rating in a research note on Tuesday, November 4th. One research analyst has rated the stock with a Buy rating, fourteen have given a Hold rating and four have issued a Sell rating to the company. According to data from MarketBeat.com, Clorox currently has a consensus rating of “Reduce” and a consensus target price of $122.88.

Clorox Price Performance

Shares of NYSE CLX opened at $106.20 on Friday. The company has a quick ratio of 0.50, a current ratio of 0.76 and a debt-to-equity ratio of 18.01. The business’s 50 day moving average price is $103.00 and its two-hundred day moving average price is $115.62. The company has a market cap of $12.95 billion, a PE ratio of 16.67, a price-to-earnings-growth ratio of 0.53 and a beta of 0.58. The Clorox Company has a twelve month low of $96.66 and a twelve month high of $164.22.

Clorox (NYSE:CLX) last released its quarterly earnings data on Monday, November 3rd. The company reported $0.85 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.78 by $0.07. Clorox had a return on equity of 358.39% and a net margin of 11.68%.The company had revenue of $1.43 billion during the quarter, compared to analysts’ expectations of $1.41 billion. During the same period last year, the firm posted $1.86 earnings per share. The business’s revenue was down 18.9% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. On average, analysts predict that The Clorox Company will post 7.15 EPS for the current year.

Clorox Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Shareholders of record on Wednesday, January 28th will be issued a $1.24 dividend. This represents a $4.96 annualized dividend and a dividend yield of 4.7%. The ex-dividend date is Wednesday, January 28th. Clorox’s payout ratio is currently 77.86%.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.